Live Quote · NASDAQFULCHealthcare· Biotechnology

Fulcrum Therapeutics, Inc.

$3.71
MKT CAP $283.38M
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
90
Valuation
20
Profitability
10
Growth
80
Health

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FULC research report →

Analyst Price Target
$3.60-3.0% vs. today

Range $3 – $4

Analyst RatingBuy
7 Buy7 Hold3 Sell

Price Chart

-67.77% · this period
$14.60$8.87$3.14Nov 19May 22Nov 19